Eledon Pharmaceuticals, Inc. Additional Paid in Capital, Preferred Stock
Eledon Pharmaceuticals, Inc. (ELDN) had Additional Paid in Capital, Preferred Stock of $420.93 million as of 2025-03-31, per its 10-Q/A filed 2025-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalPreferredStock · last filed 2025-08-14
- 2025-03-31: Additional Paid in Capital, Preferred Stock $420.93M.
- 2024-12-31: Additional Paid in Capital, Preferred Stock $417.95M.
- 2024-09-30: Additional Paid in Capital, Preferred Stock $331.19M.
- 2024-06-30: Additional Paid in Capital, Preferred Stock $323.71M.
| Period end | Additional Paid in Capital, Preferred Stock |
|---|---|
| 2025-03-31 | $420.93M 10-Q/A · filed 2025-08-14 |
| 2024-12-31 | $417.95M 10-K/A · filed 2025-08-14 |
| 2024-09-30 | $331.19M 10-K/A · filed 2025-08-14 |
| 2024-06-30 | $323.71M 10-K/A · filed 2025-08-14 |
| 2024-03-31 | $272.59M 10-K/A · filed 2025-08-14 |
| 2023-12-31 | $270.89M 10-K/A · filed 2025-08-14 |
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2016-12-31 | $291.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |